Current Vascular Pharmacology
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 3
Author(s): Stefano Taddei*
Affiliation:
- Department of Clinical and Experimental Medicine University of Pisa Pisa,Italy
Export Options
About this article
Cite this article as:
Taddei Stefano*, Meet Our Editorial Board Member, Current Vascular Pharmacology 2017; 15 (3) . https://dx.doi.org/10.2174/157016111503170411223101
DOI https://dx.doi.org/10.2174/157016111503170411223101 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Current Pharmaceutical Design Clinical Application of Ghrelin
Current Pharmaceutical Design Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities
Mini-Reviews in Medicinal Chemistry A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer
Current Cancer Drug Targets Mechanisms of Thrombosis, Available Treatments and Management Challenges Presented by Thromboangiitis Obliterans
Current Medicinal Chemistry Oxidative Stress-Induced Ischemic Heart Disease: Protection by Antioxidants
Current Medicinal Chemistry Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study
Current Vascular Pharmacology Atherosclerosis is an Inflammatory Disorder After All
Current Topics in Medicinal Chemistry Family Psychoeducation in Clinical High Risk and First-Episode Psychosis
Adolescent Psychiatry Obstructive Sleep Apnea and Obesity
Current Respiratory Medicine Reviews Pharmacotherapy of Obesity - Benefit, Bias and Hyperbole
Current Medicinal Chemistry Importance of Oral Health in Pregnancy: A Mini-symposium
Current Women`s Health Reviews Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience
Current Alzheimer Research Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets
Current Pharmaceutical Design Current Status in Iron Chelation in Hemoglobinopathies
Current Molecular Medicine Heart Failure in Chronic Myocarditis: A Role for microRNAs?
Current Genomics Carbon Nanotube-Based Electrochemical Biosensing Platforms: Fundamentals,Applications, and Future Possibilities
Recent Patents on Biotechnology Pulmonary Hypertension: Role of Combination Therapy
Current Vascular Pharmacology Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson’s Disease
Mini-Reviews in Medicinal Chemistry